196
Participants
Start Date
September 14, 2023
Primary Completion Date
March 28, 2025
Study Completion Date
July 3, 2025
BPL-003
A single dose administered intranasally
BPL-003
A single dose administered intranasally (administered as 2 nasal sprays minutes apart)
Royal Prince Alfred Hospital, Sydney
Royal Melbourne Hospital, University of Melbourne, Parkville
NeuroCentrix Research, Melbourne
Dept. of Psychiatry and School Psychological Sciences, Monash University, Clayton
New York State Psychiatric Institute, New York
Charité - Universitätsmedizin Berlin, Berlin
OVID Clinic, Augmented Psychotherapy, Berlin
Sunstone Medical PC (Sunstone Therapies / Aquilino Cancer Center), Rockville
Fundación de Investigación HM Hospital, Madrid
CenExel iResearch, Decatur
Emory University, Brain Health Center, Department of Psychiatry and Behavioral Sciences, Atlanta
CenExel ACMR, Atlanta
Centro de Salud Mental La Corredoria, Oviedo
Segal Trials Center for Psychedelic and Cannabis Research, Lauderhill
UAB School of Public Health, Department of Health Behavior, Birmingham
Centro Salud San Juan, Salamanca
University of Wisconsin, Dept of Family Medicine & Community Health, Madison
Department of Psychiatry, University Hospital Frankfurt, Frankfurt am Main
Central Institute of Mental Health, Dept. of Molecular Neuroimaging, Mannheim
Universitätsklinik für Psychiatrie und Psychotherapie, Calwerstr. 14, Tübingen
Woodland Research Northwest, Rogers
AIM Trials, Plano
Insite clinical research, DeSoto
Wholeness Center, Fort Collins
Cedar Clinical Research, Draper
Pacific Neuroscience Institute, Treatment and Research in Psychedelics (TRIP) Program, Santa Monica
Kadima Neuropsychiatry Institute, San Diego
San Francisco Insight and Integration Center, San Francisco
Portland Psychotherapy, Portland
Boston Clinical Trials, Boston
CenExel HRI, Berlin
Department of Psychiatry, UCK, Gdansk
Centrum Badań Klinicznych PI-House sp. z o.o., Gdansk
SPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Lodz
Klinika Inventiva, Tuszyn
Department of Pharmacology and Physiology of CNS, Warsaw
Hospital del Mar, Barcelona
Parc Sanitari Sant Joan de Deu HD Numancia, Barcelona
Hospital Clinic de Barcelona, Psychiatry and Psychology Dept., Barcelona
NIHR Exeter Clinical Research Facility, Exeter
King's College London - Institute of Psychiatry, Psychology & Neuroscience (IoPPN) - Centre for Affective Disorders (CfAD), London
Clerkenwell Health, London
Lead Sponsor
Beckley Psytech Limited
INDUSTRY